Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v19-FR | Version v16-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-03-12 | 2025-03-06 |
| Drug Identification Number | 02442213 | 02442213 |
| Brand name | SUFENTANIL CITRATE INJECTION USP | SUFENTANIL CITRATE INJECTION USP |
| Common or Proper name | SUFENTANIL CITRATE INJECTION USP | SUFENTANIL CITRATE INJECTION USP |
| Company Name | STERIMAX INC | STERIMAX INC |
| Ingredients | SUFENTANIL | SUFENTANIL |
| Strength(s) | 50MCG | 50MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | EPIDURAL INTRAVENOUS EPIDURAL INTRAVENOUS | EPIDURAL INTRAVENOUS EPIDURAL INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 10 X 1 mL Ampoules | 10 X 1 mL Ampoules |
| ATC code | N01AH | N01AH |
| ATC description | ANESTHETICS, GENERAL | ANESTHETICS, GENERAL |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2024-08-16 | 2024-08-16 |
| Actual start date | ||
| Estimated end date | 2025-03-14 | 2025-03-14 |
| Actual end date | 2025-03-11 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Coverage in place for contracted customers. Alternatively, Sufentanil Citrate Inj. 5 mL remains available. | Coverage in place for contracted customers. Alternatively, Sufentanil Citrate Inj. 5 mL remains available. |
| Health Canada comments |